Reaction

Therapeutic Response Changed reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 6,141 reports · 46 co-occurring drugs

As of the last recalculation, Therapeutic Response Changed appears in 6,141 FAERS reports alongside 46 co-occurring drug terms. The strongest observed disproportionality signal is TIRZEPATIDE (PRR 72.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Tirzepatide2,23172.973.9
Calcium, Magnesium, Potassium, And Sodium Oxybates5521.822.0
Lisdexamfetamine Dimesylate13213.813.9
Methylphenidate Hydrochloride1046.06.0
Guanfacine135.65.6
Infliximab-Dyyb404.74.7
Naproxen Sodium Tablet714.64.6
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, And Amphetamine Sulfate434.14.2
Dextroamphetamine Sulfate, Dextroamphetamine Saccharate, Amphetamine Sulfate And Amphetamine Aspartate483.93.9
Lamotirigine813.93.9
Lamotrigine Extended-Release813.93.9
Lamotrigine Chewable Dispersible813.93.9
Acetaminophen, Aspirin, And Caffeine223.53.6
Orlistat273.53.5
Liothyronine Sodium93.53.5
Zonisamide153.43.4
Loratadine And Pseudoephedrine Sulfate83.43.4
Armodafinil203.23.2
Methylphenidate273.23.2
Bupropion Hydrochloride883.13.1
Lamotrigine1163.03.0
Niacin102.92.9
Bupropion332.52.5
Acetaminophen, Aspirin (Nsaid) And Caffeine122.42.4
Rifampicin72.32.3
Rizatriptan Benzoate72.32.3
Duloxetine462.22.2
Ibuprofen Tablets, Coated252.02.0
Ibuprofen Sodium252.02.0
Oxybutynin172.02.0
Loratadine Tablet291.81.8
Fluticasone Propionate And Salmeterol221.81.8
Multivitamin261.81.8
Amphetamine41.61.6
Desvenlafaxine Succinate131.61.6
Lurasidone Hydrochloride101.61.6
Linaclotide121.51.5
Eptinezumab-Jjmr41.51.5
Varenicline Tartrate351.51.5
Vilazodone Hydrochloride41.51.5
Dalfampridine311.51.5
Cariprazine41.51.5
Sodium Oxybate231.21.2
Asenapine Maleate31.21.2
Paliperidone71.01.0
Teriflunomide131.01.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.